The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Immunology

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molimm.2014.09.005PMID 25242213PMCID PMC4254213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clostridium difficile

  2019cited by this paper
• Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome

  2014cited by this paper
• Small animal models for the study of Clostridium difficile disease pathogenesis.

  2014cited by this paper
• Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection

  2014cited by this paper
• Clostridium difficile infection: molecular pathogenesis and novel therapeutics

  2014cited by this paper
• Clostridium difficile flagellin stimulates toll-like receptor 5, and toxin B promotes flagellin-induced chemokine production via TLR5.

  2013cited by this paper
• Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

  2013cited by this paper
• A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile

  2013cited by this paper
• Anthracyclines induce DNA damage response-mediated protection against severe sepsis.

  2013cited by this paper
• The host immune response to Clostridium difficile infection

  2013cited by this paper
• Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

  2013cited by this paper
• The P2Y6 Receptor Mediates Clostridium difficile Toxin-Induced CXCL8/IL-8 Production and Intestinal Epithelial Barrier Dysfunction

  2013cited by this paper
• Clostridium difficile Modulates Host Innate Immunity via Toxin-Independent and Dependent Mechanism(s)

  2013cited by this paper
• Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections

  2013cited by this paper
• Murine models to study Clostridium difficile infection and transmission.

  2013cited by this paper
• Faecal transplantation for recurrent C difficile diarrhoea.

  2013cited by this paper
• Toll-Like Receptor 5-Dependent Immunogenicity and Protective Efficacy of a Recombinant Fusion Protein Vaccine Containing the Nontoxic Domains of Clostridium difficile Toxins A and B and Salmonella enterica Serovar Typhimurium Flagellin in a Mouse Model of Clostridium difficile Disease

  2013cited by this paper
• American Journal of Gastroenterology Lecture: Intestinal Microbiota and the Role of Fecal Microbiota Transplant (FMT) in Treatment of C. difficile Infection

  2013cited by this paper
• Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments

  2013cited by this paper
• The economic burden of Clostridium difficile.

  2012cited by this paper
• Immunosuppressive and biologic therapy for ulcerative colitis

  2012cited by this paper
• Toward a structural understanding of Clostridium difficile toxins A and B

  2012influential reference
• Immune responses to Clostridium difficile infection.

  2012cited by this paper
• A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection

  2012cited by this paper
• Models for the study of Clostridium difficile infection

  2012cited by this paper
• A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.

  2012cited by this paper
• Clostridium difficile: development of a novel candidate vaccine.

  2012cited by this paper
• Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis

  2012cited by this paper
• Biologic Therapy for Inflammatory Bowel Disease

  2012cited by this paper
• Clostridium difficile infection

  2012cited by this paper
• The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice

  2012cited by this paper
• Intrarectal Instillation of Clostridium difficile Toxin A Triggers Colonic Inflammation and Tissue Damage: Development of a Novel and Efficient Mouse Model of Clostridium difficile Toxin Exposure

  2012cited by this paper
• Protective Role of Commensals against Clostridium difficile Infection via an IL-1β–Mediated Positive-Feedback Loop

  2012cited by this paper
• Clostridium difficile Toxins: Mediators of Inflammation

  2012cited by this paper
• Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.

  2012cited by this paper
• Host and pathogen factors for Clostridium difficile infection and colonization.

  2011cited by this paper
• Biology of Clostridium difficile: implications for epidemiology and diagnosis.

  2011cited by this paper
• Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection

  2011cited by this paper
• The host immune response to Clostridium difficile.

  2011cited by this paper
• Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile.

  2011cited by this paper
• Mouse Relapse Model of Clostridium difficile Infection

  2011cited by this paper
• Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection

  2011cited by this paper
• Binary toxin and death after Clostridium difficile infection.

  2011cited by this paper
• Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B

  2011influential reference
• Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins

  2011cited by this paper
• Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains.

  2011cited by this paper
• Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis

  2011cited by this paper
• Toll-Like Receptor 5 Stimulation Protects Mice from Acute Clostridium difficile Colitis

  2011cited by this paper
• The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile.

  2011cited by this paper
• Super toxins from a super bug: structure and function of Clostridium difficile toxins.

  2011cited by this paper
• Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit.

  2011cited by this paper
• Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A

  2011cited by this paper
• Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the Pathogen

  2011cited by this paper
• A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins

  2011cited by this paper
• The Repetitive Oligopeptide Sequences Modulate Cytopathic Potency but Are Not Crucial for Cellular Uptake of Clostridium difficile Toxin A

  2011cited by this paper
• Membrane Translocation of Binary Actin-ADP-Ribosylating Toxins from Clostridium difficile and Clostridium perfringens Is Facilitated by Cyclophilin A and Hsp90

  2011cited by this paper
• Inhibiting the Initiation of Clostridium difficile Spore Germination using Analogs of Chenodeoxycholic Acid, a Bile Acid

  2010cited by this paper
• Future novel therapeutic agents for Clostridium difficile infection

  2010cited by this paper
• Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile

  2010cited by this paper
• Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis

  2010cited by this paper
• Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile

  2010cited by this paper
• The role of toxin A and toxin B in Clostridium difficile infection

  2010cited by this paper
• Inositol Hexakisphosphate-Induced Autoprocessing of Large Bacterial Protein Toxins

  2010cited by this paper
• Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).

  2010cited by this paper
• Infectious diarrhea

  2010cited by this paper
• Treatment with monoclonal antibodies against Clostridium difficile toxins.

  2010cited by this paper
• The Enterotoxicity of Clostridium difficile Toxins

  2010cited by this paper
• Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.

  2010cited by this paper
• Clostridium difficile.

  2009cited by this paper
• Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.

  2009cited by this paper
• A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.

  2009cited by this paper
• Trans-10, cis-12 conjugated linoleic acid modulates phagocytic responses of canine peripheral blood polymorphonuclear neutrophilic leukocytes exposed to Clostridium difficile toxin B.

  2009cited by this paper
• Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-κB signaling pathway

  2009cited by this paper
• Toxin B is essential for virulence of Clostridium difficile

  2009cited by this paper
• Clostridium difficile infection: new developments in epidemiology and pathogenesis

  2009cited by this paper
• Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria

  2009cited by this paper
• New trends in Clostridium difficile virulence and pathogenesis.

  2009cited by this paper
• Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages.

  2009cited by this paper
• A mouse model of Clostridium difficile-associated disease.

  2008cited by this paper
• Human alpha-defensins inhibit Clostridium difficile toxin B.

  2008cited by this paper
• Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

  2008cited by this paper
• Structure and mode of action of clostridial glucosylating toxins: the ABCD model.

  2008influential reference
• Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.

  2008cited by this paper
• Mammalian Rho GTPases: new insights into their functions from in vivo studies

  2008cited by this paper
• Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile

  2008cited by this paper
• Cwp84, a Surface-Associated Protein of Clostridium difficile, Is a Cysteine Protease with Degrading Activity on Extracellular Matrix Proteins

  2007cited by this paper
• Binary Toxin Production in Clostridium difficile Is Regulated by CdtR, a LytTR Family Response Regulator

  2007cited by this paper
• Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.

  2007cited by this paper
• The challenges posed by reemerging Clostridium difficile infection.

  2007cited by this paper
• Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.

  2007cited by this paper
• Clostridium difficile: Recent Epidemiologic Findings and Advances in Therapy

  2007cited by this paper
• A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

  2007cited by this paper
• Clostridium difficile Toxins A and B Directly Stimulate Human Mast Cells

  2007cited by this paper
• Risk factors for severity and relapse of pseudomembranous colitis in an elderly population

  2007cited by this paper
• Clostridium difficile Toxin B Causes Apoptosis in Epithelial Cells by Thrilling Mitochondria

  2007cited by this paper
• Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity*

  2007cited by this paper
• Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A

  2007cited by this paper
• Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains.

  2007cited by this paper
• Clostridium difficile‐associated diarrhoea

  2007cited by this paper
• Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells.

  2006cited by this paper

• Clostridioides difficile Bacteremia in an Elderly Female Patient After Colon Cancer Surgery

  2025cites this paper
• Equol neutralizes toxin B to combat Clostridioides difficile infection without disrupting the gut microbiota.

  2025cites this paper
• MOLECULAR DETECTION OF DRUG-RESISTANT GENES AMONG Clostridioides difficile FROM DIARRHEIC CHILDREN IN DUHOK CITY -IRAQ

  2025cites this paper
• Insights into the Interaction Between Clostridioides difficile and the Gut Microbiome

  2025cites this paper
• Fiber- and acetate-mediated modulation of MHC-II expression on intestinal epithelium protects from Clostridioides difficile infection

  2025cites this paper
• Probiotics Ameliorate Histological Alterations and Prevent Increases in Cytokine and Toxin Levels in Mice Infected with Various Clostridioides difficile Strains.

  2025cites this paper
• Proinflammatory pathways contribute to the pathogenesis of Clostridioides difficile infection in a murine model using Spatial transcriptomics

  2025cites this paper
• Clostridioides difficile infection in inflammatory bowel disease: a clinical review

  2024cites this paper
• Bacterial toxins induce non-canonical migracytosis to aggravate acute inflammation

  2024cites this paper
• Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection

  2024cites this paper
• Clostridium difficile Infection: Risk and Poor Prognostic Factors at a Tertiary Hospital in the Eastern Region of Saudi Arabia

  2023cites this paper
• Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection.

  2023cites this paper
• Clostridioides difficile infection: traversing host–pathogen interactions in the gut

  2023cites this paper
• Rapid visualization of Clostridioides difficile toxins A and B by multiplex RPA combined with CRISPR-Cas12a

  2023cites this paper
• Identification of Antimicrobial Resistance Genes and Drug Targets in Antibiotic-Resistant Clostridioides difficile Clinical Isolates

  2023cites this paper
• Role of probiotics in preventing Clostridioides difficile infection in older adults: an integrative review

  2023cites this paper
• Probiotics for the Prevention of Antibiotic-Associated Diarrhea

  2022cites this paper
• Clostridioides difficile – a new name, the old problems with diagnosis and treatment

  2022cites this paper
• Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers

  2022cites this paper
• Functional profile of host microbiome indicates Clostridioides difficile infection

  2022cites this paper
• Microbial Resistance to Antibiotics and Effective Antibiotherapy

  2022cites this paper
• Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease May be Favoured by the Effects of Proinflammatory Cytokines on the Enteroglial Network

  2021cites this paper
• Risk Factors Associated With Clostridium difficile-Associated Diarrhea

  2021cites this paper
• Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection

  2021cites this paper
• Effective inhibition of Clostridioides difficile by the novel peptide CM-A

  2021cites this paper
• Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico

  2021cites this paper
• Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection

  2021cites this paper
• Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B

  2021cites this paper
• #17: Disease and Immunoprophylaxis Model of Human Nose Organoids to Study SARS-CoV-2 and RSV Infection

  2021cites this paper
• Spezifische Aspekte bei Infektionserkrankungen im Alter

  2021cites this paper
• Exoproteomic analysis of two MLST clade 2 strains of Clostridioides difficile from Latin America reveal close similarities

  2021cites this paper
• Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection

  2020cites this paper
• Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction

  2020cites this paper
• A Computational Framework to Quantify Host-Microbiome Interactions in Clostridioides Difficile Infection

  2020cites this paper
• Integrating Gut Microbiota and Host Immune Markers for Highly Accurate Diagnosis of Clostridioides difficile Infection

  2020cites this paper
• Loss of IL-10 signaling promotes IL-22 dependent host defenses against acute Clostridioides difficile infection

  2020cites this paper
• Fecal Microbiota Transplant: Latest Addition to Arsenal Against Recurrent Clostridium Difficile Infection.

  2020cites this paper
• A contemporary review of Clostridioides difficile infections in patients with haematologic diseases

  2020cites this paper
• Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI)

  2019cites this paper
• Clostridium difficile infections in teaching hospital in northern Finland

  2019cites this paper
• Infections of the Luminal Digestive Tract

  2019cites this paper
• Development of antimicrobial resistance: future challenges

  2019cites this paper
• Recent advances in the treatment of C. difficile using biotherapeutic agents

  2019cites this paper
• Clostridium difficile in Swine: Zoonotic Transfer and the Potential Consequences

  2019cites this paper
• Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection

  2019cites this paper
• Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.

  2018cites this paper
• Prolonged Mechanical Ventilation Assistance Interacts Synergistically with Carbapenem for Clostridium difficile Infection in Critically Ill Patients

  2018cites this paper
• Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.

  2018cites this paper
• Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report

  2018cites this paper
• Molecular Characterization of Clostridium difficile Isolates in China From 2010 to 2015

  2018cites this paper
• Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms

  2018cites this paper
• Isolation and characterization of Clostridium perfringens bacteriophages and optimization of electro-transformation parameters for Clostridium difficile

  2018cites this paper
• Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure

  2018cites this paper
• Clostridium difficile colitis and zoonotic origins—a narrative review

  2018cites this paper
• Treatment of recurrent Clostridium difficile colitis: a narrative review

  2017cites this paper
• Pathophysiology of Enteritis and Colitis

  2017cites this paper
• The role of toxins in Clostridium difficile infection.

  2017cites this paper
• Inactivation of the dnaK gene in Clostridium difficile 630 Δerm yields a temperature-sensitive phenotype and increases biofilm-forming ability

  2017cites this paper
• Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing

  2017cites this paper
• Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients

  2016influential citation
• Chemokine CXCL13 expression was up-regulated in Clostridium difficile infection.

  2016cites this paper
• Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance

  2016cites this paper
• Type I interferons in inflammatory and infectious disease

  2016influential citation
• Resistant and Emergent Pathogens in Food Products

  2016cites this paper
• Culturing Clostridium difficile and the human gut microbiome

  2016cites this paper
• Role of Clostridium difficile Toxins in Antibiotic-Associated Diarrhea and Pseudomembranous Colitis

  2016cites this paper
• Virulence factors of Clostridium difficile and their role during infection.

  2016cites this paper
• Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.

  2016cites this paper
• Clostridium-difficile-Infektion bei geriatrischen Patienten

  2016cites this paper
• Immune responses induced by Clostridium difficile.

  2016cites this paper
• Clostridial Binary Toxins: Basic Understandings that Include Cell Surface Binding and an Internal "Coup de Grâce".

  2016cites this paper
• Clostridium Difficile Infection Due to Pneumonia Treatment: Mortality Risk Models.

  2016cites this paper
• [Clostridium difficile infections in geriatric patients].

  2016cites this paper
• Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects

  2016cites this paper
• Host response to Clostridium difficile infection: Diagnostics and detection.

  2016cites this paper
• Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

  2016cites this paper
• Clostridium difficile infection

  2016cites this paper
• Choix et impact d’un algorithme diagnostique pour les infections à Clostridium difficile : de la compréhension de la physiopathologie de l’infection au choix de la méthode diagnostique

  2016cites this paper
• Effect of maternal antibiotic intervention in sows on gut development and microbiota in offspring : report of Feed4Foodure, VDI-2: 2013/2014

  2015cites this paper
• Silver and other metals in the treatment of gastrointestinal diseases.

  2015cites this paper
• Investigation of microbial interactions of Lactobacillus paracasei CNCM I-1518 with elderly gut microbiota and Clostridium difficile using advanced intestinal fermentation models

  2015cites this paper
• Secretory diarrhoea: mechanisms and emerging therapies

  2015cites this paper
• Étude des riborégulateurs guanine et de l'impact des gènes qu'ils régulent sur la biologie de Clostridium difficile 630

  2015cites this paper
• Differences of the Fecal Microflora With Clostridium difficile Therapies.

  2015cites this paper
• Monitoring in real time the cytotoxic effect of Clostridium difficile upon the intestinal epithelial cell line HT29.

  2015cites this paper